Suggestions
Lucy Setian
Expert in Digital Transformation and Innovation
Lucy Setian is the Director of Patient Experience Strategy and Solutions in Hematology at Novartis, based in Basel, Switzerland. She has a strong background in digital transformation and health technology innovation, having previously held the position of Director of Digital Transformation at the Novartis Foundation since August 2021. Prior to that, she served as Associate Director of HealthTech Innovation at the same foundation from January 2020 to August 2021.
Her career includes significant roles in various organizations, such as UCB, where she worked as the Lead of Technology Practice and Senior Manager of Digital Services. She has also contributed as an independent innovation expert for the European Commission and has experience in marketing and digital strategy consulting.
Lucy Setian is recognized for her focus on creativity in solving systemic problems and has a range of certifications in project management, agile methodologies, and strategic thinking, reflecting her commitment to continuous professional development and innovation in healthcare.12
Highlights
Few months ago, as I was invited to give a keynote at the EVG Events Group Global Women in Leadership Summit 2024 in Amsterdam, a cold shiver went through me, as I was thinking what useful can I possibly share in front of so many successful women. As the weeks went by, one topic seemingly stayed stuck in my head, as it turns out to be a central theme in my professional and personal life. Leadership, success stories, how-to-s, and such, I thought I'm going to step back and look through the lens of my life so far and tell a bit of my story. Hence I've decided to spend a good chunk of the next weeks to ponder over what I have struggled with for many years (and still do): the topic of failure. After all, I thought, I have experienced so many and so diverse forms of failures, that this should be a no-brainer. As I was amidst of planning my expedition into failure (+ the Amazonian jungle), the most amazing news came totally out of nowhere as a testament that success and failure are never that far apart. After one year of waiting, I received the news that I am awarded the highly competitive Women's Scholarship to pursue the MSc in Global Healthcare Leadership at the University of Oxford. Being one of only two women to receive it in 2024, is such an honor on itself and even more so in a field in which so many talented professionals are pouring their all into making a lasting impact for health systems, organizations and people around the world. The program brings together two outstanding research departments from Saïd Business School, University of Oxford and Nuffield Department of Primary Care Health Sciences - University of Oxford, harnessing the University’s world-leading expertise in healthcare, business and policy.
It is true honor to be amongst the ranks of Oxford. Often being recognized as a high potential female leader from a minority background is seen as a nice-to-have in the fill-out org chart numbers but not a real corporate culture organizational thesis and belief.
It's time to change that. And while the path to failure often feels as a lonely one, the path to success is the one you choose for yourself - in the right company. I'm excited to share more live on 25-27th of Sept in Amsterdam, and wishing you all a powerful summer rejuvenation!
#newbeginnings #newway #learntofail #healthcareleaders
An overwhelmingly busy two weeks from the European Hematology Association congress #EHA24 in Madrid to #HLTH Europe conference in Amsterdam.
From a medical and clinical community to a digital and AI technology-first innovation ecosystem, some similarities come across these two very diverse groups:
- co-creation through partnerships is the only way to advance health care, delivery and products
- education and skills transformation are absolutely essential across all parts of the health system: for HCPs, patients, industry executives, regulators, startup founders, investors,...
- AI technology is a catalyst and accelerator for personalization and prevention,... but it also can cause disruption, increase risks and supersede the speed of regulatory readiness
- access and affordability are top of mind not only for drugs and treatments but also for healthtech services and solutions
- health data-sharing, privacy and usage are still making everyone nervous (for decades now)
What are your takeaways from these two large congresses?
#hematology #patientexperience #innovation #oncology #healthtech #aihealth
Personal views only.
